Concepedia

J. Vidal Barrull

JV

Statistics

Publications

2

Citations

300

H-Index

2

Active since

2019

Affiliations

Vall d'Hebron Hospital Universitari(Current)

J. Vidal Barrull is an author at Vall d'Hebron Hospital Universitari specializing in oncology, pharmacology, and medicine.

Publications per year

2019–2024

2

Publications

2

Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial

Charles S. Fuchs, Kohei Shitara, Maria Di Bartolomeo et al. · The Lancet Oncology · 2019 · 284 citations · Full text

, , +13

511MO Third line rechallenge with cetuximab (Cet) and irinotecan in circulating tumor DNA (ctDNA) selected metastatic colorectal cancer (mCRC) patients: The randomized phase II CITRIC trial

C. Santos Vivas, J. Vidal Barrull, C. Fernandez Rodriguez et al. · Annals of Oncology · 2024 · 16 citations · Full text

, , +15

1–2 of 2